DK1406895T3 - Lactonformuleringer og fremgangsmåde til anvendelse deraf - Google Patents
Lactonformuleringer og fremgangsmåde til anvendelse derafInfo
- Publication number
- DK1406895T3 DK1406895T3 DK02734779T DK02734779T DK1406895T3 DK 1406895 T3 DK1406895 T3 DK 1406895T3 DK 02734779 T DK02734779 T DK 02734779T DK 02734779 T DK02734779 T DK 02734779T DK 1406895 T3 DK1406895 T3 DK 1406895T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- lactone
- formulations
- lactone formulations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Furan Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29787501P | 2001-06-13 | 2001-06-13 | |
PCT/US2002/018602 WO2002100854A1 (en) | 2001-06-13 | 2002-06-12 | Lactone formulations and method of use |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1406895T3 true DK1406895T3 (da) | 2008-12-01 |
Family
ID=23148076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02734779T DK1406895T3 (da) | 2001-06-13 | 2002-06-12 | Lactonformuleringer og fremgangsmåde til anvendelse deraf |
Country Status (21)
Country | Link |
---|---|
US (3) | US6900242B2 (pt) |
EP (1) | EP1406895B1 (pt) |
JP (1) | JP2005500289A (pt) |
KR (1) | KR20040030676A (pt) |
AR (1) | AR036056A1 (pt) |
AT (1) | ATE406367T1 (pt) |
AU (1) | AU2002306150B2 (pt) |
BR (1) | BR0210432A (pt) |
CA (1) | CA2450660C (pt) |
CO (1) | CO5550429A2 (pt) |
CY (1) | CY1108590T1 (pt) |
DE (1) | DE60228576D1 (pt) |
DK (1) | DK1406895T3 (pt) |
ES (1) | ES2315365T3 (pt) |
IL (3) | IL159296A0 (pt) |
MX (1) | MXPA03011554A (pt) |
PT (1) | PT1406895E (pt) |
RS (1) | RS52139B (pt) |
UY (1) | UY27334A1 (pt) |
WO (1) | WO2002100854A1 (pt) |
ZA (1) | ZA200400208B (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002306150B2 (en) | 2001-06-13 | 2008-02-14 | Magnachem International Laboratories, Inc. | Lactone formulations and method of use |
JP4869597B2 (ja) | 2002-11-05 | 2012-02-08 | マグナケム インターナショナル ラボラトリーズ, インコーポレイテッド | 合成ラクトン処方物ならびに使用方法 |
US20050045197A1 (en) * | 2003-08-28 | 2005-03-03 | Gelder Steven K. | Multiple drug delivery system & method |
WO2005102315A1 (en) * | 2004-04-23 | 2005-11-03 | Magnachem International Laboratories, Inc. | Synthetic lactone formulations for pain control |
EP2350645A2 (en) * | 2008-10-24 | 2011-08-03 | Magnachem International Laboratories, Inc. | Method for screening for compounds selectively interacting with rad9 |
CN103099901B (zh) * | 2013-01-26 | 2014-07-30 | 张红 | 一种治疗子宫内膜移位症的中药灌肠剂 |
KR101988479B1 (ko) * | 2017-10-11 | 2019-09-24 | (주)휴럼 | 리트세노라이드를 유효성분으로 하는 헬리코박터 파이로리 균주로부터 유래되는 위장질환 예방 및 치료용 약학 조성물 |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2624723A (en) * | 1947-03-03 | 1953-01-06 | Allied Chem & Dye Corp | Lactone derivatives and method of making |
US2624732A (en) * | 1950-05-10 | 1953-01-06 | Burroughs Wellcome Co | Preparation of 5-benzyl-2,4-diaminopyrimidines |
US3203953A (en) * | 1963-01-18 | 1965-08-31 | Ciba Geigy Corp | Lactone obtained from helenium sp. and derivatives thereof |
US3210377A (en) * | 1963-06-05 | 1965-10-05 | Olin Mathieson | Gamma lactones |
US4001425A (en) * | 1974-04-17 | 1977-01-04 | E. I. Du Pont De Nemours And Company | Methods of treating hypertension and pharmaceutical compositions comprising 1-tertiary-alkyl-3-(substituted furyl)ureas as antihypertensive agents |
JPS5111173B2 (pt) * | 1974-04-25 | 1976-04-09 | ||
JPS51125722A (en) | 1975-01-13 | 1976-11-02 | Sumitomo Chem Co Ltd | Germicides for industry and their preparation |
JPS597713B2 (ja) | 1977-12-19 | 1984-02-20 | 三井東圧化学株式会社 | 新規γ↓−ブチロラクトン誘導体とその製造法 |
JPS56128776A (en) | 1980-03-14 | 1981-10-08 | Otsuka Pharmaceut Factory Inc | Alpha-methylene gamma-butyrolactone derivative |
JPS58199413A (ja) | 1982-05-13 | 1983-11-19 | Pioneer Electronic Corp | デイジタル変調信号の読取装置 |
JPS6058973A (ja) * | 1983-09-13 | 1985-04-05 | Mitsubishi Yuka Yakuhin Kk | γ−プチロラクトン誘導体及びそれを有効成分とする免疫調節剤 |
JPS6226221A (ja) | 1985-07-29 | 1987-02-04 | Japan Tobacco Inc | 抗変異原性剤 |
JP2524760B2 (ja) | 1987-07-10 | 1996-08-14 | テイカ株式会社 | 新規抗生物質 |
JPH01163175A (ja) | 1987-12-21 | 1989-06-27 | Ss Pharmaceut Co Ltd | フラン−2−オン誘導体 |
US5242945A (en) * | 1991-04-12 | 1993-09-07 | American Home Products Corporation | Tetronic and thiotetronic acid derivatives as phospholipase a2 inhibitors |
US5250735A (en) * | 1992-04-03 | 1993-10-05 | University Of Pittsburgh | 2-(N-substituted-aminoalkyl)-5-(E)-alkylidene cyclopentanones, 2-(N-substituted-aminoalkyl)-5-(E)-arylalkylidene cyclopentanones, and derivatives thereof |
TW354294B (en) * | 1993-09-17 | 1999-03-11 | Upjohn Co | Substituted tetronic acids useful for treating HIV and other retroviruses |
US5595756A (en) | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
EP0854139B1 (en) * | 1994-06-07 | 2001-09-05 | Teijin Limited | Vitamin D3 derivative and production process thereof |
AUPN191295A0 (en) | 1995-03-23 | 1995-04-27 | Unisearch Limited | Microbiocide or microbial regulator |
US5962460A (en) * | 1995-06-27 | 1999-10-05 | National Science Council (Taiwan) | Antineoplastic α-methylene-γ-butyrolactones |
US5646164A (en) * | 1995-11-14 | 1997-07-08 | National Science Council | α-methylene-γ-butyrolactones: new inhibitors of platelet aggregation |
WO1997018806A1 (en) | 1995-11-17 | 1997-05-29 | The Johns Hopkins University | Inhibition of fatty acid synthase as a means to reduce adipocyte mass |
US6222048B1 (en) * | 1995-12-18 | 2001-04-24 | Merck Frosst Canada & Co. | Diaryl-2-(5H)-furanones as Cox-2 inhibitors |
US5618835A (en) | 1996-02-01 | 1997-04-08 | The Procter & Gamble Company | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
US6180651B1 (en) * | 1996-04-04 | 2001-01-30 | Bristol-Myers Squibb | Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics |
US5981575A (en) * | 1996-11-15 | 1999-11-09 | Johns Hopkins University, The | Inhibition of fatty acid synthase as a means to reduce adipocyte mass |
US5939455A (en) | 1997-03-11 | 1999-08-17 | Beacon Laboratories, Inc. | Therapeutic augmentation of oxyalkylene diesters and butyric acid derivatives |
JP2001518087A (ja) | 1997-04-02 | 2001-10-09 | メルク フロスト カナダ アンド カンパニー | 選択的シクロオキシゲナーゼ−2阻害薬としてのα−メチレン−γ−ラクトン類 |
US5905089A (en) * | 1997-04-14 | 1999-05-18 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Use of sesquiterpene lactones for treatment of severe inflammatory disorders |
AUPP303498A0 (en) | 1998-04-17 | 1998-05-14 | Unisearch Limited | Inhibition of gram positive bacteria |
EP1085845A2 (en) * | 1998-06-08 | 2001-03-28 | Advanced Medicine, Inc. | Multibinding inhibitors of cyclooxygenase-2 |
BR0010768A (pt) * | 1999-03-30 | 2002-01-15 | Du Pont | Processo de preparação de "alfa"-metilenolactonas |
FR2801792B1 (fr) | 1999-12-01 | 2003-04-18 | Sod Conseils Rech Applic | Un nouveau medicament, le dihydromikanolide, son obtention par extraction de la plante mikania micrantha et son utilisation comme agent anti-proliferatif |
US6660511B1 (en) | 2000-03-03 | 2003-12-09 | Rigel Pharmaceuticals, Inc. | Methods of screening for modulation of cell cycle |
US6686390B2 (en) * | 2000-05-22 | 2004-02-03 | Dr. Reddy's Laboratories Limited | Compounds having antiinflamatory activity: process for their preparation and pharmaceutical compositions containing them |
JP2002037797A (ja) | 2000-07-25 | 2002-02-06 | Kanegafuchi Chem Ind Co Ltd | マクロファージ選択的細胞死誘導物質 |
PL361879A1 (en) | 2001-01-12 | 2004-10-04 | Societe De Conseil De Recherches Et D'applications Scientifiques, S.A.S. | Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
AU2002306150B2 (en) * | 2001-06-13 | 2008-02-14 | Magnachem International Laboratories, Inc. | Lactone formulations and method of use |
US6686724B2 (en) * | 2002-05-21 | 2004-02-03 | Ford Motor Company | Method of and apparatus for controlling charging and/or discharging of a battery for a hybrid electric vehicle |
JP4869597B2 (ja) * | 2002-11-05 | 2012-02-08 | マグナケム インターナショナル ラボラトリーズ, インコーポレイテッド | 合成ラクトン処方物ならびに使用方法 |
WO2005102315A1 (en) * | 2004-04-23 | 2005-11-03 | Magnachem International Laboratories, Inc. | Synthetic lactone formulations for pain control |
-
2002
- 2002-06-12 AU AU2002306150A patent/AU2002306150B2/en not_active Ceased
- 2002-06-12 US US10/172,462 patent/US6900242B2/en not_active Expired - Lifetime
- 2002-06-12 WO PCT/US2002/018602 patent/WO2002100854A1/en active Application Filing
- 2002-06-12 DK DK02734779T patent/DK1406895T3/da active
- 2002-06-12 BR BR0210432-6A patent/BR0210432A/pt not_active IP Right Cessation
- 2002-06-12 PT PT02734779T patent/PT1406895E/pt unknown
- 2002-06-12 AT AT02734779T patent/ATE406367T1/de active
- 2002-06-12 CA CA2450660A patent/CA2450660C/en not_active Expired - Fee Related
- 2002-06-12 KR KR10-2003-7016356A patent/KR20040030676A/ko active Search and Examination
- 2002-06-12 ES ES02734779T patent/ES2315365T3/es not_active Expired - Lifetime
- 2002-06-12 EP EP02734779A patent/EP1406895B1/en not_active Expired - Lifetime
- 2002-06-12 MX MXPA03011554A patent/MXPA03011554A/es active IP Right Grant
- 2002-06-12 JP JP2003503621A patent/JP2005500289A/ja active Pending
- 2002-06-12 DE DE60228576T patent/DE60228576D1/de not_active Expired - Lifetime
- 2002-06-12 IL IL15929602A patent/IL159296A0/xx unknown
- 2002-06-12 RS YU98603A patent/RS52139B/en unknown
- 2002-06-13 AR ARP020102236A patent/AR036056A1/es not_active Application Discontinuation
- 2002-06-13 UY UY27334A patent/UY27334A1/es not_active Application Discontinuation
-
2003
- 2003-12-10 IL IL159296A patent/IL159296A/en not_active IP Right Cessation
-
2004
- 2004-01-09 CO CO04001331A patent/CO5550429A2/es not_active Application Discontinuation
- 2004-01-12 ZA ZA2004/00208A patent/ZA200400208B/en unknown
-
2005
- 2005-05-26 US US11/139,338 patent/US20050209316A1/en not_active Abandoned
-
2008
- 2008-11-24 CY CY20081101353T patent/CY1108590T1/el unknown
-
2010
- 2010-12-15 US US12/968,508 patent/US8536348B2/en not_active Expired - Fee Related
-
2011
- 2011-03-27 IL IL211958A patent/IL211958A0/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RS98603A (en) | 2006-12-15 |
US6900242B2 (en) | 2005-05-31 |
US20110092588A1 (en) | 2011-04-21 |
AR036056A1 (es) | 2004-08-04 |
AU2002306150B2 (en) | 2008-02-14 |
MXPA03011554A (es) | 2004-10-28 |
CA2450660C (en) | 2011-08-16 |
DE60228576D1 (de) | 2008-10-09 |
US20050209316A1 (en) | 2005-09-22 |
UY27334A1 (es) | 2003-02-28 |
EP1406895B1 (en) | 2008-08-27 |
US8536348B2 (en) | 2013-09-17 |
ATE406367T1 (de) | 2008-09-15 |
IL159296A0 (en) | 2004-06-01 |
IL211958A0 (en) | 2011-06-30 |
CA2450660A1 (en) | 2002-12-19 |
ES2315365T3 (es) | 2009-04-01 |
CY1108590T1 (el) | 2014-04-09 |
RS52139B (en) | 2012-08-31 |
KR20040030676A (ko) | 2004-04-09 |
JP2005500289A (ja) | 2005-01-06 |
BR0210432A (pt) | 2004-08-03 |
ZA200400208B (en) | 2005-06-29 |
CO5550429A2 (es) | 2005-08-31 |
EP1406895A1 (en) | 2004-04-14 |
IL159296A (en) | 2011-06-30 |
EP1406895A4 (en) | 2004-11-17 |
PT1406895E (pt) | 2008-11-04 |
US20030069393A1 (en) | 2003-04-10 |
WO2002100854A1 (en) | 2002-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1417175T3 (da) | Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf | |
DK1242095T3 (da) | Antimikrobielle sammensætninger og fremgangsmåder til anvendelse deraf | |
NO20041975D0 (no) | Bicyklisk oksopyridin og oksopyrimidinderivater | |
DK1370128T3 (da) | Kombineret ballepresse og ballevikler | |
IS6934A (is) | Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar | |
NO20033556L (no) | Farmasöytiske formuleringer | |
NO20044192L (no) | 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater | |
DK1339292T3 (da) | Sammensætning og fremgangsmåde | |
IS8153A (is) | Ónæmisbælandi efnasambönd og efnablöndur | |
DK1539224T3 (da) | Antimikrobielt præparat og fremgangsmåde til anvendelse | |
DK1429769T3 (da) | Nye formuleringer og anvendelse deraf | |
NO20025357D0 (no) | Antranylamider og deres anvendelse som legemidler | |
NO20034159L (no) | Östrogen-gestagen-kombinasjonspreparat og anvendelse derav | |
NO20033854L (no) | N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse | |
NO20021786D0 (no) | Skumdempningsfremgangsmåter og sammensetninger | |
DK1601744T3 (da) | Forgasningsapparat og fremgangsmåde | |
ATE502118T1 (de) | Amplifizierungsverfahren | |
DK1417189T3 (da) | Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf | |
NO20043333L (no) | Farmasoytiske parvastatinformuleringer og fremgangsmater for anvendelse av dem | |
NO20033506D0 (no) | Parasittdrepende preparater og fremgangsmåter for anvendelse | |
DE60201856D1 (de) | Klasse-D Verstärker | |
NO20030843D0 (no) | Anordning og fremgangsmåte for kultivering | |
NO20030156L (no) | Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav | |
DK1406895T3 (da) | Lactonformuleringer og fremgangsmåde til anvendelse deraf | |
IS2331B (is) | 2-arýlimínó-2,3-díhýdróþíasólafleiður, aðferðir til að framleiða þær og meðferðarfræðileg notkun þeirra |